Palliative treatment of coronary “atherosclerotic cancer” by drug-eluting or bare-metal stents: From oculo-stenotic reflex period to age of precision medicine

Simple item page
dc.contributor.authorCetin, Elif Hande Ozcanen_US
dc.contributor.authorOzeke, Ozcanen_US
dc.contributor.authorIlkay, Erdoganen_US
dc.contributor.authorAras, Dursunen_US
dc.contributor.authorTopaloglu, Serkanen_US
dc.contributor.authorGolbasi, Zehraen_US
dc.contributor.authorAydogdu, Sinanen_US
dc.contributor.authorOzer, Canen_US
dc.date.accessioned2020-01-02T06:41:10Z
dc.date.available2020-01-02T06:41:10Z
dc.date.issued2018-01
dc.description.abstractMedications and treatments are said to have a palliative effect if they relieve symptoms without having a curative effect on the underlying disease such as atherosclerosis or cancer. Some authors speculated that atherosclerotic coronary artery disease (CAD) could be considered a “cancer of the coronary arterial wall”. Although the percutaneous coronary intervention (PCI) has proven to be effective in decreasing mortality rates among patients with acute coronary syndromes, the previous meta-analyses of PCI versus optimal medical therapy for stable CAD have not been able to demonstrate a reduction in major adverse cardiac outcomes. However, few cardiologists discussed the evidence-based benefits of angiogram and PCI for stable CAD, and some implicitly or explicitly overstated the benefits. Recently, the precision medicine is defined as an evidence-based approach that uses innovative tools and biological and data science to customize disease prevention, detection, and treatment, and improve the effectiveness and quality of patient care. Providing patients with accurate and complete information appears to be an effective way to combat the reliance on the oculostenotic reflex. The foundation of precision medicine is the ability to tailor therapy based upon the expected risks and benefits of treatment for each individual patient. As said by Doctor William Osler, “The good physician treats the disease; the great physician treats the patient who has the disease.”en_US
dc.identifier.affiliationsHealth Sciences University, Turkiye Yuksek Ihtisas Training and Research Hospital , Department of Cardiology, Ankara, Turkeyen_US
dc.identifier.citationCetin Elif Hande Ozcan, Ozeke Ozcan, Ilkay Erdogan, Aras Dursun, Topaloglu Serkan, Golbasi Zehra, Aydogdu Sinan, Ozer Can. Palliative treatment of coronary “atherosclerotic cancer” by drug-eluting or bare-metal stents: From oculo-stenotic reflex period to age of precision medicine. Indian Heart Journal. 2018 Jan; 70(1): 191-193en_US
dc.identifier.issn0019-4832
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/191763
dc.languageenen_US
dc.publisherCardiological Society of Indiaen_US
dc.relation.issuenumber1en_US
dc.relation.volume70en_US
dc.source.urihttps://doi.org/10.1016/j.ihj.2017.07.008en_US
dc.subjectAtherosclerosisen_US
dc.subjectAtherothrombosisen_US
dc.subjectCoronary stentsen_US
dc.subjectDrug eluting stentsen_US
dc.subjectAtherosclerotic canceren_US
dc.titlePalliative treatment of coronary “atherosclerotic cancer” by drug-eluting or bare-metal stents: From oculo-stenotic reflex period to age of precision medicineen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ihj2018v70n1p191.pdf
Size:
270.36 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Heart Journal